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Abstract
A systematic review and meta-analysis was conducted to investigate the effects of yoga on
glycemic control, lipid profiles, body composition and blood pressure in people in the pre-
diabetic state. Studies on the effectiveness of yoga on population groups under high risk for
diabetes, called prediabetic or suffering from metabolic syndromes were extracted from a
thorough search of PubMed, Scopus, Cochrane Library, EBSCO and IndMED databases.
Both Randomised Controlled Trial (RCT) and non-RCT studies were included in the system-
atic review and meta-analysis. Studies published between Jan 2002 and Dec 2018 were
included. Studies were considered for evaluation if they investigated a yoga intervention to
prevent T2DM, against a control group, while also reporting glycemic control and other
health parameters of T2DM management. Summary effect sizes and 95% confidence inter-
vals (CI) were calculated using the Comprehensive Meta-Analysis software in addition to
publication bias. Of the 46,500 identified studies, 14 studies with 834 participants of whom
were 50% women, were found to be eligible for inclusion in our systematic review. Our quan-
titative synthesis included 12 randomized control trials and 2 non-randomized control trials,
with the follow-up period ranging from 4 to 52 weeks. Compared to controls, yoga interven-
tion improved fasting blood glucose (FBG) [Standard Mean Difference (SMD -0.064 mg/dL
(95% CI -0.201 to 0.074)]; low density lipoprotein (LDL) [SMD-0.090 mg/dL (95% CI -0.270
to 0.090)]; triglycerides [SMD -0.148 mg/dL (95% CI -0.285 to -0.012)]; total cholesterol
[SMD -0.058 mg/dL (95% CI -0.220 to 0.104)] and systolic blood pressure [SMD -0.058 mm
Hg (95% CI -0.168 to 0.053)]. This meta-analysis uncovered clinically improved effects of
yoga intervention on glycemic control, lipid profiles and other parameters of T2DM manage-
ment in prediabetic population. These results suggest that yoga intervention may be consid-
ered as a comprehensive and alternative approach to preventing T2DM. Further adequately
powered, well designed RCTs are needed to support our findings and investigate the long-
term effects of yoga in T2DM patients.
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Introduction
Type II diabetes mellitus is a chronic metabolic disease characterized by persistent hyperglyce-
mia because of a progressive condition in which the body becomes resistant to the typical
effects of insulin or loses the ability to produce insulin [1]. The global prevalence of diabetes
among adults above 18 years old has increased to 8.5% in 2014 from 4.7% in 1980. Approxi-
mately 422 million people were found to be living with diabetes in 2014 [2] and approximately
1.6 million deaths were directly caused by diabetes in 2016 [3].
The key risk factors often associated with the development and maintenance of Type 2 dia-
betes mellitus (T2DM) include sedentary lifestyle [4], or an unhealthy diet and psychological
stress. Psychological stress is strongly associated with both the risk factors [5–7] and mainte-
nance of the disease [8, 9]. In addition to the genetic background, the prediabetic state also
contributes significantly to the development of T2DM [4, 10].
The critical components of diabetes management are medication, diet and physical activity/
exercise [11]. However, many complementary and alternative practices have been used by peo-
ple in both the prevention and treatment of diabetes [12, 13] such as yoga. Yoga originated in
India over 5000 years ago as a form of traditional mind-body training [14, 15]. The efficacy of
yoga has been studied in several chronic diseases, such as hypertension, asthma, chronic
obstructive pulmonary disease and diabetes [16–18].
Previous studies have reported that the practice of yoga might reduce Insulin Resistance
Syndrome, is an exclusive collection of risk factors for the development of T2DM and have
shown promising results in improving signs, improving prognosis and reducing complications
[16, 18–22]. Furthermore, studies showed the development of diabetes from the prediabetic
state could be either delayed or ameliorated by consistent physical activity [23–26], healthy
diet [24] and active stress management [27, 28].
Previous studies have highlighted that yoga could lessen fasting blood glucose (FBG) and
glycosylated hemoglobin A1c (HbA1c) as well as reduce the lipid levels while improving the
quality of life of T2DM patients [29–36]. However, these studies showed inconclusive results
with wide variations in their sample size. A limitation of the study may include the inclusion
of a few studies based on a non-randomized study design, not informed so could potentially
impact the outcome [32, 33, 35]. Nevertheless, a few previously published systematic reviews
have reported the efficacy of yoga on blood glucose levels, insulin sensitivity, oxidative stress,
lipid profile, anthropometric measures, pulmonary measures, nerve conduction and quality of
life for T2DM with promising results [37–40]. Raveendran and colleagues demonstrated the
role of various yoga practices in the management of diabetes based on evidence from various
clinical studies [41].
The promising benefits of yoga interventions for T2DM have also been recorded in a recent
meta-analysis. Innes and Selfi demonstrated the impact of yoga among adults with T2DM to
improve glycemic control, lipid levels and body composition measured by body weight and
mass index from a systematic review of 25 controlled trials [42]. Cui and colleagues reported
a meta-analysis of 12 randomized controlled trials and highlighted the progress in pooled
weighted mean differences for fasting blood glucose and hemoglobin A1c. The authors of this
particular study also measured the weighted effect size of yoga efficacy for postprandial blood
glucose (PPBS), total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein
cholesterol and triglycerides [11]. Kumar and colleagues documented beneficial effects of yoga
as a complementary intervention to standard treatment in comparison to standard treatment
on FBS for PPBS and HbA1C [43]. Thind and colleagues showed, in their meta-analysis that
yoga T2DM participants were successful in improving their HbA1c, FBG and PPBG, in addi-
tion to significant improvements in lipid profile, blood pressure, body mass index, waist/hip
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ratio and cortisol level [44]. Because past meta-analysis has not been conducted on the effects
yoga on prediabetic populations, we carried out a meta-analysis of RCT and non-RCT studies
in the present study to determine the effectiveness of yoga in patients with high-risk T2DM.
We hypothesize that yoga intervenes T2DM by two proposed mechanisms: downregulation of
both the hypothalamic pituitary adrenal axis and the sympathetic nervous system [45–47].
Rationale
What is the issue and how will our study address this? Studies published previously in
the prediabetic population showed the effectiveness of yoga in reducing the risk of progression
to diabetic state [48–50]. There are a few systematic reviews and meta-analyses that demon-
strate the efficacy of yoga in T2DM. However, there is currently no systematic review and
meta-analysis study that details the potential benefits of yoga in the prediabetic population.
This is the first such study to show evidence that yoga intervention may impact the prediabetic
state by assessing the glycemic control (HbA1c, fasting blood glucose (FBG) and postprandial
glucose (PPBG) in both the intervention and control group conditions. This study also
summarises the results of other markers of diabetes management including triglycerides, high-
density lipoprotein, low-density lipoprotein, systolic and diastolic blood pressure, body com-
position and fasting cortisol, as influenced by yoga in prediabetic populations. The study pro-
vides further evidence that yoga intervention could be considered as an effective alternate
treatment or lifestyle therapy for people who are under high risk of T2DM.
Review questions
Our systematic review and meta-analysis sought to clarify the association between yoga inter-
vention and prediabetic state. We also compared the overall effect of the yoga intervention on
glycemic control and other markers of diabetes management.
The questions for this review are as follows:
• Does yoga delay or prevent the progression of diabetes in a prediabetic population?
• What is the significance of yoga compared to exercise in a prediabetic population?
• How much does the effect size of physiological outcomes vary between studies?
Methods
This systematic review and meta-analysis was registered in the PROSPERO (Registration
number CRD 42018106657) database and followed the Preferred Reporting Items for System-
atic Review and Meta-Analysis (PRISMA) guidelines [51]. This protocol has been published in
Medicine Journal.
Search strategy
We searched 5 electronic bibliographic databases: PubMed, Scopus, Cochrane Library,
EBSCO and IndMED using a combination of search terms for the effectiveness of yoga on peo-
ple with high risk of diabetes or prediabetic population, or metabolic syndrome ((yoga, cardio-
vascular disease risk factors, prediabetes state, high risk for diabetes, metabolic syndrome,
glucose, type II diabetes, exercise therapy and type 2 diabetes patients)) [52]. Two authors per-
formed title and abstract screening and then accessed potential full-text eligible articles. The
corresponding author performed a final assessment on eligible studies for inclusion, and the
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references of eligible studies were imported into an EndNote file to create an initial list of eligi-
ble studies and avoid duplication. Any discrepancies associated with the selection of the studies
were resolved by mutual discussions involving a third reviewer. The entire selection process is
illustrated in Fig 1.
Study selection criteria
The included studies had to meet the following (PICO) criteria
Inclusion criteria.
• Participants (P): Participants with prediabetic or designated as high risk for diabetes because
of physiological measures.
• Intervention (I): Inclusion of studies was dependent on the program following authentic or
traditional yoga rules and techniques. Studies examining yoga intervention including at least
one of asana, pranayama, meditation to promote T2DM management and comparing it with
a control. Studies with randomised control trial’, randomised cross-over studies, cluster-ran-
domised trials, or quasi-experimental design were included.
• Control (C): Any control with other usual care or physical exercise or non-therapeutic
intervention
• Outcomes (O): Studies evaluating glycemic control as well as other measures of T2DM man-
agement such as HbA1c, blood pressure, fasting blood sugar, lipid profile (triglycerides, high
and low-density lipoprotein (HDL and LDL) cholesterol), systolic blood pressure and dia-
stolic blood pressure in both the intervention and control group conditions.
Fig 1. A flowchart depicting the study selection and the search results.
https://doi.org/10.1371/journal.pone.0221067.g001
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Exclusion criteria.
• We excluded study participants who were members of a specific age group, such as adoles-
cents or geriatric age groups
• Study participants were all in a transient state, such as pregnancy or menopause
• Studies were excluded if the yoga intervention was modified to a dance program
• Studies from conference proceedings, editorials, commentaries, book chapters and book
reviews were excluded.
Data extraction and management
Two authors developed a data extraction form using MS Excel and independently evaluated
the published studies with the predefined selection criteria for inclusion into the review. Data
were extracted based on six categories: 1. Study information (first author, year of publication,
country, a journal of publication, the study period); 2. Study design and methods (a type of
research, details of randomised control trial, randomised cross-over studies and cluster-rando-
mised trials or quasi-experimental design and the validity of confirmative diagnosis and
method of data collection); 3. Study participants characteristics (condition, age, gender, race,
sample size and sampling procedures); 4. Yoga intervention characteristics (Yoga type: asana,
pranayama, meditation, components, frequency, duration); 5. Control intervention character-
istics (Type: usual care or physical exercise or non-therapeutic intervention, frequency, dura-
tion); 6. Outcome measures (Primary and secondary outcome measures, assessment time
points, blood pressure (systolic, diastolic); heart rate; respiratory rate; abdominal obesity
(waist circumference, waist-hip ratio, index of central obesity); blood lipid levels (triglycerides,
high and low-density lipoprotein (HDL and LDL) cholesterol); glycemic control (both the
intervention and control group conditions, such as HbA1c, blood pressure, or fasting blood
sugar).
Study outcomes
Primary outcome. The primary outcome was the measurement of glycemic control
(HbA1c) fasting blood glucose (FBG) and postprandial glucose (PPBG).
Secondary outcomes. The secondary outcomes were other markers of diabetes manage-
ment including triglycerides, high-density lipoprotein, low-density lipoprotein, systolic and
diastolic blood pressure, body composition and fasting cortisol.
Assessment of risk of bias
Risk of bias of included studies was assessed using the Cochrane Risk of Bias Assessment tool.
This tool assesses several items under seven categories such as random sequence generation,
allocation concealment, blinding of participants and investigators, the blindness of outcome
assessments, incomplete outcome data, selective outcome reporting, and other biases. Based
on the assessment, the studies were evaluated as low, unclear, or high bias. The PRISMA
checklist is given in S1 Table.
The Jadad scale was used to evaluate the quality of each study in which three domains in the
scale cover randomization (0–2 points), blinding (0–2 points), and dropouts and withdrawals
(0–1 point) [53]. A trial with a score of� 2 indicates low quality whereas a score of�3 indi-
cates high quality. Assessment of publication bias was performed using funnel plots generated
by Comprehensive Meta-Analysis (CMA) 3.0 software.
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Data synthesis
Meta-analysis-assessment of overall effect size. Meta-analyses were performed using
CMA, and the effectiveness of yoga interventions on the glycemic status of the prediabetic
population was computed. We combined effect sizes across included studies and reported
pooled effect estimate as standardised mean difference (SMD) with their 95% Confidence
Intervals (CI). Random-effects model of the meta-analysis was followed, and forest plots were
generated to visually assess the pooled effect size of the study’s findings.
The outcome measures in this systematic review and meta-analysis were continuous. Nega-
tive SMDs indicated better performances of yoga interventions on the glycemic status and
other markers of the prediabetic population or the beneficial effects of yoga for diabetes risk
[43].
Assessment of heterogeneity
Heterogeneity in effect size was assessed using the Cochrane Q test and I2-statistic. Q statistics
and the associated degree of freedom were estimated for each outcome. Q statistics provides a
test of the null hypothesis that all studies in the proposed meta-analysis share a standard effect
size. If all studies shared the same effect size, the expected value of Q would be equal to the
degrees of freedom the number of studies minus 1. I2 statistics reflect the proportion of the
observed variance that informs the difference in true effects sizes rather than the sampling
error of the included studies. The tau-squared parameter indicates information of the hetero-
geneity between the effects for the test accuracy observed in different studies [54].
Publication bias
Publication bias of the included studies was assessed using Egger’s bias indicator test. Orwin’s
[55] and classic fail-safe N test’ [56], ‘Begg and Mazumdar Rank correlation test’ [57], and
‘Duval and Tweedie’s Trim and Fill ‘calculations [58] were used to impute missing small stud-
ies with large effect size to be dispersed equally on either side of the overall effect, to provide a
more accurate estimate of the likely publication bias
Funnel plot. The funnel plot is a plot of study size (standard error or precision) on the
vertical axis versus a function of effect size (standard mean difference) on the horizontal axis.
The included studies in the plot are distributed symmetrically about the combined effect size
in the absence of publication bias. This plot was generated using Egger’s test [59]. Conversely,
a higher concentration of studies is observed on one side of the mean than the other in the
presence of bias.
Classic fail-safe N and Orwin fail-safe N. The critical reason for publication bias is that
some non-significant studies are missing from this meta-analysis. The observed effect of yoga
intervention will be invalidated if these missing studies are included in the analysis. If the miss-
ing number is relatively small, publication bias is likely. However, if these missing number of
studies are large, the findings are interpreted as the intervention effect of yoga could be possi-
bly inflated by the exclusion of some studies, is nevertheless not nil [60]. Both Classic and the
Orwin fail-safe N reports the likelihood that studies are absent from the analysis and that these
studies if included in the analysis, would shift the effect size toward the null [55].
Begg and Mazumdar rank correlation test. In general, extensive studies tend to be
included in the quantitative synthesis or meta-analysis regardless of their yoga intervention
and control group effects while small studies are more possible to be included when they dis-
play a comparatively sizeable intervention effect. Therefore, an inverse correlation between
study size and effect size will tend to be observed. Begg and Mazumdar proposed that this kind
of correlation can aid as a test for publication bias [61]. Therefore, the rank order correlation
Yoga practice on glycemic control and other health parameters in the prediabetic state
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was computed (Kendall’s tau b) between the intervention effect and the standard error (which
is driven primarily by sample size).
Egger’s test of the intercept. The Egger regression yields the degree of funnel plot asym-
metry or the same bias by using precision -the inverse of the standard error to predict the stan-
dardised effect (effect size divided by the standard error). The Egger’s Test of the Intercept was
undertaken to gauge the relationship between test accuracy estimates and their precision [59].
Duval and Tweedie’s Trim and Fill. Duval and Tweedie’s Trim and Fill test imputes the
missing studies of both yoga and control conditions are, add them to the analysis, and then
recomputes the combined intervention effect. The 'Trim and Fill' method iteratively prunes
the asymmetric studies from the right-hand side to localize the unbiased effect. Then this
method completes by re-introducing the trimmed studies on the right as well as their imputed
counterparts to the left of the mean intervention effect [62].
Subgroup analyses
Subgroup analyses were performed based on study, participant and outcome characteristics
and methodological factors. We have investigated specific subgroup analyses according to dif-
ferences in intervention and critical features of identified study participants such as glycemic
control (both the intervention and control group conditions, such as HbA1c, blood pressure,
or fasting blood sugar), blood lipid levels (low density lipoprotein (LDL), triglycerides, choles-
terol), body composition (waist circumference and body weight) and blood pressure (systolic,
diastolic).
Results
In total, 46,500 studies were identified by searching the bibliographic databases PubMed, Sco-
pus, Cochrane Library, EBSCO and IndMED with search strings of keywords. Of these studies,
45270 studies were excluded because they were either irrelevant topics or inappropriate stud-
ies. Finally, 1230 articles were screened for further evaluation. A third reviewer monitored the
review process to validate the complete study search and selection of most relevant studies for
inclusion and monitored the review process. After removing the duplicates and abstract
screening, 1216 articles were excluded, because the articles were either reviews, letters to the
editor or case studies. This exclusion step resulted in 14 studies after careful manual screening.
The reference lists of the existing narrative reviews and meta-analysis were checked and
revealed no further relevant missed studies. Finally, 14 studies were eligible for inclusion in
our systematic review. Also, some studies failed to mention the association between yoga and
metabolic syndrome. Therefore, a final total of 14 studies were included in the systematic
review. The study selection is depicted in Fig 1.
Of the 14 studies, six were from India, four from USA, two from China and one each from
Sweden and Hong Kong. The total population included in this study was 834 participants
from 14 studies. The gender details were available in 10 of the included 14 studies in the sys-
tematic analysis. In the total 14 studies, 285 males and 413 females were reported. Our quanti-
tative synthesis demonstrated that 12 studies were randomised control trial, and two were
non-randomized control trial. The follow-up period ranged from 4 to 52 weeks. The interven-
tions were yoga practitioners, pre-diabetic, diabetic, obese and metabolic syndrome, as indi-
cated in Table 1.
Analysis of the overall effects of yoga intervention
Fourteen studies reported FBG as a primary outcome. The effects of yoga compared to control
conditions were observed for the pooled SMD (glycemic control) of FBG was -0.064 mg/dL
Yoga practice on glycemic control and other health parameters in the prediabetic state
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(95% CI -0.201 to 0.074); PPBG was 0.268 mg/dL (95% CI 0.006–0.530); and HbA1c was
0.021% (95% CI -0.164 to 0.205). Relative to controls, the subgroup analysis of other measures
of T2DM management revealed effects of yoga compared to controls for lipid profile, body
compositions and blood pressure. The efficacy of yoga compared to control for pooled SMD
(lipid profile) of LDL was -0.090 mg/dL (95% CI -0.270 to 0.090); triglycerides was -0.148 mg/
dL (95% CI -0.285 to -0.012); and total cholesterol was -0.058 mg/dL (95% CI -0.220 to 0.104).
The pooled SMD (body composition) for waist circumference was 0.023 cm (95% CI -0.206 to
0.251) and body weight was 0.045 kg (95% CI -0.338 to 0.427). The mean SMD (blood pres-
sure) for systolic blood pressure was -0.058 mm Hg (95% CI -0.168 to 0.053); and diastolic
blood pressure was 0.010 mm Hg (95% CI -0.098 to 0.117).
Sensitivity analysis
In the included studies with a low risk of selection bias using random sequence generation, all
studies were located. A significant effect of yoga in comparison to control group conditions
was observed in pooled SMD of the primary outcome measure. In the case of allocation con-
cealment, which is a source of bias, most of the studies except six generated high and unclear
Risk of Bias assessment (ROB). This could imply that the results were not distinguishable from
potential bias. In RCTs with low risk of detection bias (Blinding of Outcome Assessment), thir-
teen studies were located. In RCTs with a low risk of attrition bias (Incomplete Out-come
Data), one study was identified. The risk of biases is shown in Table 2.
Primary outcome -Glycemic control
The beneficial outcomes were noticed in fasting blood glucose, but not in postprandial glucose
and glycosylated hemoglobin (HbA1c).
Fasting blood glucose. The meta-analysis revealed that yoga is beneficial in the control of
blood sugar levels compared to control group conditions.
Does yoga intervention decrease fasting blood glucose level? Fourteen studies provided
the SMD values for the meta-analysis on the fasting blood glucose; the point estimate of effect
size for random effects of SMD was -0.064 (95% CI -0.201 to 0.074) (Fig 2).
How much does the effect size of yoga efficacy differ across studies? The Q statistics
provide a test of the null hypothesis that all RCTs in the meta-analysis share a standard effect
size. If all RCTs shared the same effect size, the expected value of Q would be equal to degrees
of freedom. The Q value is 21.75 with 14 degrees of freedom and a corresponding P-value =
0.084. The I2 statistic indicates the proportions of the observed variance that reflects the differ-
ence in actual effect sizes rather than sampling error. Here I2 was 35%. T2 (tau2 is the variance
of true effect sizes and tau2 = 0.024.
Postprandial blood glucose. Four studies provided the SMD values for the meta-analysis
on the postprandial blood glucose; the point estimate for random effects ratio of SMD was
0.268 (95% 0.006 to 0.530) with the degrees of freedom (df) = 3, I2<7.756, P-value = 0.354 and
tau2 = 0.007.
Glycosylated hemoglobin (HbA1c). Four studies provided the SMD values for the meta-
analysis on the HbA1c; the point estimate for random effects ratio of SMD was 0.021 (95% CI-
0.164 to 0.205) with the degrees of freedom (df) = 3, I2<0.000, P-value = 0.978 and tau2 = 0.000.
Secondary outcomes
Lipid profile. Yoga intervention was successful in reducing all three measures of the lipid
profile of yoga participants who exhibited lower LDL, triglycerides and total cholesterol com-
pared to controls.
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Low-density lipoprotein (LDL). Five studies provided the SMD values for the meta-anal-
ysis on the low-density lipoprotein; the point estimate for random effects ratio of SMD was
-0.090 (95% CI -0.270 to 0.090) with the degrees of freedom (df) = 4, I2<0.000, P-value = 0.930
and tau2 = 0.000.
Triglycerides. Nine studies provided the SMD values for the meta-analysis on the triglyc-
erides; the point estimate for random effects ratio of SMD was -0.148 (95% CI -0.285 to
-0.012) with the degrees of freedom (df) = 8, I2<0.000, P-value = 0.669 and tau2 = 0.000.
Total cholesterol. Seven studies provided the SMD values for the meta-analysis on the
total cholesterol; the point estimate for fixed effects ratio of random effects ratio of SMD was
-0.058 (95% CI -0.220 to 0.104) with the degrees of freedom (df) = 6, I2<0.000, P-value = 0.792
and tau2 = 0.000.
Body composition. On subgroup analysis, no effect on body composition was observed
in the yoga intervention group as compared with the control conditions.
Table 2. Risk of bias assessment of the included studies.
S.No Author and
Year
Random
sequence
generation
(Selected bias)
Allocation
concealment
(selection bias)
Blinding of
participants and
personnel
(performance bias)
Blinding of
outcome
assessment
(detection bias)
Incomplete
outcome data
(Attrition bias)
Selective
reporting
(reporting bias)
Other
bias
Jadad
Score
1 Corey SM et al.
2014 [81]
Low risk unclear High risk High risk High risk Low risk Unclear 2
2 Hegde et al.
2013 [49]
Low risk Low risk High risk Low risk Low risk Low risk Low
risk
4
3 Kanaya Am
et al. 2014 [72]
Low risk Low risk High risk Low risk Low risk Low risk Low
risk
3
4 Keerthi GS
et al. 2017 [66]
Low risk High risk Low risk Low risk Low risk Low risk Low
risk
3
5 Lau Caren et al.
2015 [83]
Low risk Low risk Low risk Low risk Low risk Low risk Low
risk
3
6 McDermott
KA et al. 2014
[69]
Low risk Low risk Low risk Low risk Low risk Low risk Low
risk
4
7 Netam et al.
2015 [67]
Low risk High risk Low risk Low risk Low risk Low risk Low
risk
3
8 Siu et al. 2015
[84]
Low risk High risk Low risk Low risk Low risk Low risk Low
risk
3
9 Sohl et al. 2016
[71]
Low risk High risk Low risk Low risk Low risk Low risk Low
risk
3
10 Supriya et al.
2017 [73]
Low risk High risk Low risk Low risk Low risk Low risk Low
risk
3
11 Tyagi A et al.
2014 [68]
Low risk Unclear Low risk Low risk Low risk High risk Unclear 2
12 Wolff M et al.
2013 [85]
Low risk High risk Low risk Low risk Low risk Low risk Low
risk
3
13 Yadhav et al.
2018 [70]
Low risk Low risk Low risk Low risk Low risk Low risk Low
risk
4
14 Yang K et al.
2011 [86]
Low risk Low risk Low risk Low risk Low risk Low risk Low
risk
4
Jadad Score:
Randomisation (0–2 points), blinding (0–2 points)
Dropouts and withdrawals (0–1 point)
Score�2 indicates low quality, whereas a score of�3 indicates high quality
https://doi.org/10.1371/journal.pone.0221067.t002
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Waist circumference. Yoga intervention was less successful in decreasing waist circum-
ference. Sixteen studies provided the SMD values for the meta-analysis on the waist circumfer-
ence; the point estimate for random effects ratio of SMD was 0.023 (95% CI -0.206 to 0.251)
with the degrees of freedom (df) = 15, I2<83.872, P-value = 0.000 and tau2 = 0.171.
Body weight. Ten studies provided the SMD values for the meta-analysis on the body
weight; the point estimate for random effects of SMD 0.045 (95% CI -0.338 to 0.427) with the
degrees of freedom (df) = 9, I2<89.974, P-value = 0.000 and tau2 = 0.328.
Blood pressure. The aggregated results suggested that yoga intervention was successful in
reducing systolic blood pressure, but not diastolic, blood pressure.
Systolic blood pressure (mmHg). Participants in yoga intervention showed a decrease in
systolic blood pressure compared to controls. Fifteen studies provided the SMD values for the
meta-analysis on the systolic blood pressure; the point estimate for random effects ratio of
SMD-0.058 (95% CI -0.168 to 0.053) with the degrees of freedom (df) = 14, I2<3.352, P-value =
0.414 and tau2 = 0.002.
Diastolic blood pressure (mmHg). Fourteen studies provided the SMD values for the
meta-analysis on the diastolic blood pressure; the point estimate for random effects ratio of
0.010 (95% CI -0.098 to 0.117) with the degrees of freedom (df) = 14, I2<0.000, P-value =
0.485 and tau2 = 0.000. The effect size estimate of Glycemic control, lipid profile, body compo-
sition and blood pressure is shown in Table 3.
Publication bias
Funnel Plots for all outcome measures are represented in Fig 3. Because the intervention effect
estimated from a biased collection of studies would tend to overestimate the exact intervention
effect, researches must assess the likely extent of the bias and the impact of this goes on the
conclusions. The detailed explanation of the publication bias among the included studies that
Fig 2. Forest plot of the effect of yoga on glycemic control, lipid profile, body composition and blood pressures in prediabetes. A) fasting blood
glucose, B) Postprandial blood glucose, C) Glycosylated hemoglobin (HbA1c), D) LDL, E) Triglycerides, F) Total Cholesterol (TC), G) Waist
circumferences, H) Body weight, I) Systolic blood pressure (SBP) and J) Diastolic blood pressure (DBP). The pooled SMD data were calculated and
analysed using CMA software (version 3.3.070, USA). The black diamond represents the pooled effect estimate of SMD of the included. The red square
with line indicates the effect size of miRNA of the included studies with 95% confidence interval.
https://doi.org/10.1371/journal.pone.0221067.g002
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examined fasting blood glucose is shown in Fig 2 and Table 4 shows the publication bias of
remaining outcome measures.
Classic fail-safe N. This meta-analysis incorporates data from 15 studies, which yield a z-
value of -1.44545 and a corresponding 2-tailed p-value of 0.14833. Although the pooled result
is not statistically significant, the Fail-Safe N -which addresses the concern that the observed
significance may be spurious is not relevant.
Orwin fail-safe N. First, the mean STD difference in means in the added studies can be
a value other than the nil value 0. Second, the criterion value is an effect size rather than a
p-value. That is, the Orwin fail-safe N is the number of added studies that will shift the com-
bined STD difference in means past a specified threshold from the starting point of 0.
Table 3. Effect size estimate of outcome measures in prediabetes state (glycemic control, lipid profile, body com-
position and blood pressure.
Outcomes Measures No of
studies
Sample size ES 95% CI I2 Tau2 Q Z
Yoga Control Low High
Glycemic
control
FBG 15 722 720 -0.037 -0.14 0.067 35.654 0.024 21.757 -0.908
HbA1c 4 232 220 0.021 -0.164 0.205 0 0 0.196 0.218
PBG 4 137 135 0.268 0.006 0.53 7.756 0.007 3.252 2.008
Lipid profile LDL 5 243 234 -0.9 -0.27 0.09 0 0 0.863 -0.984
Triglycerides 9 424 408 -0.148 -0.285 -0.012 0 0 5.801 -2.133
Total
cholesterol
7 299 288 -0.058 -0.22 0.104 0 0 3.136 -0.701
Body
composition
WC 16 1022 1021 0.023 -0.206 0.251 83.872 0.171 93.005 0.194
Body weight 10 607 608 0.045 -0.338 0.427 89.974 0.328 89.77 0.228
Blood
pressure
SBP 15 667 670 -0.058 -0.168 0.053 3.352 0.002 14.486 -1.021
DBP 15 667 670 0.01 -0.098 0.117 0 0 13.529 0.173
FBG: Fasting Blood Glucose; ES: Effect Size; CI: Confidence Interval; PBG: Prandial Blood Glucose; LDL: Low
Density Lipoprotein; WC: Waist Circumference; SBP: Systolic Blood Pressure; DBP: Diastolic Blood Pressure.
https://doi.org/10.1371/journal.pone.0221067.t003
Fig 3. Funnel plot of yoga intervention efficacy on glycemic control, lipid profile, body composition and blood pressure in
prediabetes. A) Fasting blood glucose (FBS), B) Postprandial blood glucose, C) Glycosylated hemoglobin (HbA1c), D) LDL, E)
Triglycerides, F) Total Cholesterol (TC), G) Waist circumferences, H) Body weight, I) Systolic blood pressure (SBP), and J)
Diastolic blood pressure (DBP).
https://doi.org/10.1371/journal.pone.0221067.g003
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Begg and Mazumdar rank correlation test. The Kendall’s tau b is -0.39423, with a
1-tailed p-value of 0.02123 or a 2-tailed p-value of 0.04246.
Egger’s test of the intercept. The Eggers bias indicator test predicted that the intercept
(B0) is -1.81427, 95% confidence interval (-3.67106, 0.04253), with t = 2.11089, df = 13. The
1-tailed p-value (recommended) is 0.02736, and the 2-tailed p-value is 0.05472.
Duval and Tweedie’s Trim and Fill. The test is in search of missing studies dependent on
a fixed effect model and represents missing studies only to the left side of the mean interven-
tion effect. Using these parameters, the method suggests that no studies are missing. Under the
fixed effect model, the point estimate and 95% confidence interval for the combined studies is
0.13277 (0.04490, 0.22064). Using Trim and Fill the imputed point estimate is the same value
above. Under the random effects model, the point estimate and 95% confidence interval for
the combined studies is 0.02255(-0.20574, 0.25084). Using Trim and Fill the imputed point
estimate is the same value as mentioned above.
Discussion
Summary of the key finding
We conducted as a systematic and meta-analysis to explore the association between yoga inter-
vention and prediabetes state. This study was designed to address whether yoga delays or pre-
vent the progression of diabetes in prediabetic population especially compared to exercise. The
meta-analysis examined whether yoga improves glycemic control, lipid profile, body composi-
tion and blood pressure in prediabetes individuals. Fasting blood glucose, LDL, triglycerides,
total cholesterol and systolic blood pressure were reduced by 0.064 mm Hg, 0.090 mg/dL,
0.148 mg/dL, 0.058 mg/dL, and 0.058 mmHg respectively.
Consistent with previous systematic review and meta-analysis
To our knowledge, no previous systematic review and meta-analysis have investigated the
effect of yoga intervention on the prediabetic state. Therefore, our findings in the prediabetic
population are consistent with studies that reported the effects of yoga practice on T2DM.
Table 4. Publication bias of the included studies.
Key variables Outcome
measures
Classic fail-
safe N
Orwin
fail-safe N
Begg and Mazumdar Egger’s
regression
Duval and
Tweedie
Z
value
P
value
SDM Tau Z
value
P
value
Glycemic
control
FBG 1.419 0.155 0.132 -0.291 1.575 0.115 -3.65 0.132
HbA1c 0.313 0.754 0.02 0.8 1.358 0.174 0.723 0.005
PPBG -0.942 0.346 -0.09 0 0 1 -0.07 -0.09
Lipid profile LDL -0.942 0.346 -0.09 0 0 1 -0.07 -0.09
Triglycerides -0.703 0.481 -0.058 -0.15 0.45 0.652 -0.143 -0.058
Total
cholesterol
-2.103 0.035 -0.148 -0.114 0.417 0.676 -0.219 -0.148
Body
composition
WC -1.445 0.148 -0.036 -0.394 2.028 0.042 -1.814 -0.036
Body weight 2.108 0.035 0.248 -0.088 0.357 0.72 -5.014 0.248
Blood
pressure
SBP -1.656 0.097 -0.053 -0.285 1.484 0.137 -1.749 -0.053
DBP -0.02 0.983 0.009 0.171 0.89 0.373 -0.439 0.009
FBG: Fasting Blood Glucose; ES: Effect Size; CI: Confidence Interval; PPBG: Postprandial Blood Glucose; LDL: Low-
Density Lipoprotein; WC: Waist Circumference; SBP: Systolic Blood Pressure; DBP: Diastolic Blood Pressure.
https://doi.org/10.1371/journal.pone.0221067.t004
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Results on fasting plasma glucose (FPG) levels and lipid profiles are similar to studies that
report a general effect of Yoga in diabetic patients [38, 63]. The findings of this systematic
review on yoga on prediabetes included 12 RCTs and two non-RCTs and show that a yoga
intervention could improve fasting blood glucose, lipid profiles and systolic blood pressure.
More specifically, yoga intervention lowered lipid profiles such as LDL, TC, and triglycerides.
Similarly, a previously published qualitative review on yoga for T2DM that included 4 RCTs
and 21 non-RCTs concluded that yoga might improve glucose tolerance, lipid profiles (LDL,
TC), anthropometric measures, and blood pressure in T2DM [64].
Consistent with the previous meta-analysis, Cui and colleagues demonstrated, in their
meta-analysis with 12 RCTs with a total of 864 patients, that yoga could significantly decrease
FBG, PPBG, HbA1c, TC and LDL levels [11]. Eun and Doi showed in a meta-analysis with 11
RCTs with a total of 993 participants that yoga intervention improves glycemic control and
lipid profiles in T2DM [63]. Similar findings were observed in Thind and colleagues’ meta-
analysis study on 23 studies investigating glycemic control, lipid profile, blood pressure and
body mass index [44]. Kumar and colleagues showed similar observations with 17 studies
focusing on three parameters of glycemic control [43]. Jayawardena and colleagues demon-
strated that significant reduction in FBG, PPBG, HbA1c and BMI alter in ’Yoga group com-
pared to the control group; however, they did not observe any significant difference between
the two groups on lipid parameters, other body composition measures (WC and WHR) and
Blood Pressure [65].
Applicability of evidence
The included studies in the meta-analysis were obtained from the currently available pool of
research, in this field and included 12 RCTs and two non-RCTs. There were four studies from
the USA, two studies from China, 1 study from Hongkong, six studies from India and 1 study
from Sweden. The studies were drawn using the defined inclusion and exclusion criteria. This
meta-analysis included studies with diverse age and ranged from 18 to 75 years old. The stud-
ies included 285 men and 413 women. The conclusive findings apply to diverse population
and age groups.
Approximately 50% of studies [49, 66–70] and the first author from three studies that were
conducted in other countries [71–73], were of Indian origin. Because yoga is centered part of
Indian tradition and culture, the intervention would be more effective in this nation. Indeed,
the implementation of yoga might be different India. For example, Kumar and colleagues
revealed that Indian experimental studies had offered yoga intervention for six days a week in
the majority of cases whereas studies performed outside countries delivered their intervention
on two days per week [43]. Cramer and colleagues highlighted that the key reasons for the pos-
itive clinical outcomes and performance in Indian yoga studies could be that yoga interven-
tions are more intense compared to non-Indian trials. They also added that the key reason for
better performance and positive outcomes in Indian yoga studies could be the difference in
skills of the yoga trainer trained and practising in India [74]. The findings from this systematic
review and meta-analysis could apply to the clear majority of healthy as well as to non-diabetic
people with a high risk for T2DM in clinical practice.
Quality of evidence
In this meta-analysis and subgroup analysis, we determined whether the outcome measures
FBG, PPBG, HbA1c, TC, Triglycerides, LDL, waist circumferences, Body weight, SBP, and
DBP from different studies exhibited clinical and statistical heterogeneity across the studies.
Therefore, the estimated effect size of the standard mean difference between yoga interventions
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and control conditions for prediabetes state were calculated by using random-effects models in
our analysis.
The quality assessment of these included studies was performed using the Jadad score and
investigated key rigorous study parameters such as randomisation, blinding, allocation con-
cealment, usage of multiple interventions and adjustment for confounders, dropouts and
withdrawals. The included studies exhibited diverse parameters in this systematic review, indi-
cating a moderate to high-quality level score [63, 75, 76]. Publication bias for ten different out-
comes of T2DM management in prediabetes state was investigated using six different tools
including inverted funnel plot, Orwin fail-safe N test, Classic fail-safe N test, Begg and Mazum-
dar Rank Correlation test, Harbords-Eggers test of intercept and Duval and Tweedie’s Trim
and Fill method. Publication bias can compromise the integrity of any meta-analysis. Without
assessing publication bias could be conveyed as null results or missing studies. Our findings
showed that the publication bias was unlikely to occur in this meta-analysis. However, in two
outcomes measures including body weight and total cholesterol, the number of missing studies
would bring p-value >0.05 was 2, and thus these parameters might exhibit publication bias.
Strengths and limitations
This systematic review and meta-analysis are the first to explore the impact of a yoga interven-
tion for the prediabetes state. This systematic review and meta-analysis were performed by
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines
[40], and the protocol has been registered in the International prospective register of system-
atic reviews (PROSPERO). The included studies comprised of 12 RCTs (one three-arm RCT,
two arm RCTs and 9 RCTs) and two non-RCTs. These studies investigated a diverse popula-
tion with a wide range of age groups. In this systematic review and meta-analysis, clinical
applicability and quality of evidence of the included studies were compared with ten different
outcome measures between yoga and control conditions.
The interpretation of the effect size of glycemic control and other three key outcomes is lim-
ited by the non-availability and insufficient reporting of PPBG, HbA1c and other outcome
measures. These issues might influence the inadequate definition of subgroups, substantial dif-
ferences in interventions, control conditions, and outcome assessment [77, 78].
The follow-up duration in the RCT in most of the included studies ranged from 4 weeks to
1 year. The authors reported limited information about RCT study participant’s withdrawals
and lost to follow. The outcome measures of the included studies were primarily calculated
after follow-up. No reporting of intervention fidelity or inadequate reporting of baseline mea-
sures and demographic characteristics of participants (sample size) were observed. Two RCTs
have reported three phases of yoga: Asanas, Pranayama and meditation. However, other infor-
mation on yoga such as yoga postures, style of yoga (i.e. Vinyasa, Ashtanga, Iyengar, Kripalu,
and Kundalini), intensity and duration of individual yoga asana or posture, type and duration
of mediation were not reported in detail [44].
Future recommendations
Future studies must follow CONSORT statement for RCTs and TREND statement for non-
RCTs to avoid inadequate reporting of sample size, randomization, allocation concealment,
intention-to-treat analysis, and blinding of at least outcome assessors [44, 79, 80]. Thind and
colleagues proposed that future studies should also report and record any adverse effects or
injuries associated with yoga intervention [44].
Only a single study investigated the effects of yoga on oxidative stress [49], cortisol [81],
inflammatory marker [67], or biometric measures [71], with only two studies available on
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anthropometric measures [66, 68]. All these parameters have been demonstrated to be impor-
tant factors for cardiovascular (what?) and T2DM [74]. Therefore, future studies should
consider evaluating these measures in their assessment. Future research focuses on yoga inter-
ventions with an emphasis on asanas, pranayama and meditation in addition to sathivka
(healthy vegetarian diet) diet and yogic life-style [74, 82].
Conclusion
This meta-analysis of yoga for diabetes and associated factors revealed evidence for the poten-
tial clinically important effect of yoga on ameliorating diabetes factors such as fasting blood
glucose, postprandial blood glucose, body weight, systolic blood, diastolic blood pressure,
LDL, triglycerides, total cholesterol and HbA1c. However, well-designed RCTs are needed to
examine the long-term efficacy of yoga intervention not only for the risk of T2DM but also
metabolic syndrome and cardiovascular disease.
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